Genetic Disorder Patients Take Aim At US Over Drug Shortages

Law360, New York (February 22, 2012, 6:47 PM EST) -- More than two dozen people with a rare genetic disorder sued three federal agencies Friday in Washington federal court, saying the government didn't do enough to ensure that Genzyme Corp. maintained adequate drug supplies after a prolonged shortage in medicine used to treat the disease.

The suit, brought by a group of people who have Fabry disease, claims the U.S. Department of Health and Human Services, the U.S. Food and Drug Administration and the National Institutes of Health did not take proper enforcement actions against Genzyme...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.